Wolfgang Huber

Group Leader and Senior Scientist
More …

Simone Bell

Simone has a degree in Nutrition Sciences and Home Economics from the Niederrhein University of Applied Sciences, Mönchengladbach. She acts as Projects and Communications Officer.
More …

Dorothee Childs

Dorothee has a PhD in Bioinformatics and a degree in Applied Mathematics; she works on quantitative proteomics in a collaboration with Cellzome.

Sascha Dietrich

Sascha is an MD in Haematology; he shares his time between the University Clinic, the National Center for Tumour Diseases and EMBL, where his research focuses on precision oncology.
More …

Jennifer Hüllein

Jennifer has a PhD in Biology from the University Heidelberg. She joined EMBL in January 2017 and is working on the SOUND project. Her main tasks are the management of data resources and data analysis workflows related to the SMART project “Drug perturbation profiling of primary blood cancers” which encompasses researchers and activities at EMBL, NCT Heidelberg, DKFZ and Heidelberg University Hospital.
More …

Vladislav Kim

Graduate student at University of Heidelberg; IT trainee at EMBL.

Bernd Klaus

Bernd has a PhD in Statistics from the University of Leipzig, Germany. He runs the Centre for Statistical Data Analysis.
More …

Junyan Lu

Junyan has a PhD in Computational Biology and Drug Design from Shanghai Institute of Materia Medica, Chinese Academy of Sciences. His previous research focused on understanding mechanisms of drug response using integrated multi-omics technology and large scale ex-vivo drug testing approaches. In November 2015, he joined the Huber Group as a postdoctoral fellow and is now working on the SOUND project.

Almut Lütge

Almut is a master student in molecular biotechnology at the University of Heidelberg. She joined the Huber group in 2017 and works on the analysis of RNA-seq data from Chronic lymphatic leukemia (CLL) samples.

Andreas Mock

Andy is training to become a physician-scientist. He holds an MPhil in Computational Biology from the University of Cambridge and is in his final year of medical studies at the University of Heidelberg. Andy is intrigued by the prospects and challenges of Omics-driven Precision Oncology. At EMBL, he is working on a joint project between EMBL, the National Center for Tumor Diseases (NCT Heidelberg) and the Heidelberg University Hospital to unravel the epigenetic determinants of drug responses in primary blood cancer patients.

Andrzej Oleś

Andrzej has a PhD in Theoretical Physics and a M.Sc. in Applied Computer Science from the Jagiellonian University in Krakow, Poland. He works as a Scientific Programmer and Technical Writer.

Małgorzata Oleś

Gosia holds a MSc in Biophysics and a BSc in Applied Computer Science from the Jagiellonian University in Krakow, Poland. During her doctoral studies at EMBL she was working on pharmacogenomics of primary cancer blood cells. She successfully defended her PhD in March 2017.
More …

Thomas Schwarzl

Tom has a PhD in Bioinformatics and Systems Biology from University College Dublin in Ireland. As EIPOD postdoctoral fellow, he is studying novel RNA-binding dynamics of metabolic enzymes. More …

Mike Smith

Mike joined EMBL as part of the de.NBI project where he is working on the development pipelines, workflows and computational approaches for large scale biological experiments. He has a PhD in computational biology from the University of Cambridge, UK.
More …

Arne Smits

Arne has a PhD degree from the Radboud University (Nijmegen, The Netherlands). His previous research in the laboratory of Prof. Michiel Vermeulen focused on the identification and quantification of protein-protein and DNA-protein interactions using quantitative proteomics. As a EIPOD postdoctoral fellow at EMBL, he is studying the systems-wide effects of drug treatment in collaboration with Cellzome and the Steinmetz group.

Britta Velten

Britta has a MSc in Mathematics from the University Heidelberg. She joined the Huber group in 2015 for her PhD. Here, she is working on statistical methodology for the analysis of high-dimensional biological datasets.

Frederik Ziebell

Frederik has a PhD in Applied Mathematics from Heidelberg University and the German Cancer Research Center (DKFZ). He works on developing statistical methods for high-dimensional heterogeneous data and the analysis of multi-omic level drug treatment effects in collaboration with Cellzome.